Reference Laboratory

Please select the first letter of the test you are interested in viewing or
click NEW for a complete listing of our newest assays.


	Enter Test Name(s) / Code(s):	Test Title	Description	Category Search:


All words must appear Any word can appear

Reference Laboratory
Tests

2453

Myasthenia Gravis Panel 2

See individual assay for desription.

Panel includes:

Acetylcholine Receptor Antibody, Binding
Acetylcholine Receptor Antibody, Blocking
Acetylcholine Receptor Antibody, Modulating

This panel includes assays for all 3 types of acetylcholine receptor antibodies (ACRAB binding, modulating, and blocking antibodies), the antibodies most commonly associated with Myasthenia gravis (MG).

†This test was developed and its performance characteristics determined by Focus Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.

Test performed at Quest Diagnostics Nichols Institute.

Methodology		Radiobinding Assay and RIA (Radioimmunoassay)
Reference Range		By report
Preferred Specimen		1 mL serum (minimum 0.5 mL)
Transport Temperature		Room temperature
Results Available		2 to 9 days
CPT Code		83519 x 3†

-169

Neuropathy Antibody Testing

First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics

FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics� Focus Diagnostics

Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.

Focus Diagnostics receives NYSDOH exemption for Diagnostic Immunology and Serology testing services

Focus Diagnostics Launches Laboratory Test for Chikungunya Virus

Back to top